#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Krabbe's disease B-cell type acute leukaemia Arterial disorder Oesophageal squamous cell carcinoma stage II Squamous cell carcinoma of the cervix Follicular lymphoma stage III Haemophilia A without inhibitors Infantile apnoea Ureteric cancer Retinal artery occlusion X-linked lymphoproliferative syndrome Systemic lupus erythematosus Autoimmune disorder Pyruvate dehydrogenase complex deficiency Pancreatic carcinoma metastatic More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Trials in Disease Nephrotic syndrome Glomerulonephritis membranoproliferative – Diagnostics Breast angiosarcoma Chronic granulomatous disease – Basic Information MELAS syndrome – Life with Disease Urea cycle disorder – Diagnostics Sarcoidosis – Life with Disease Pemphigoid – Trials in Disease Gaucher’s disease type III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabigatran Etexilate Deutivacaftor Isoniazid Pf-06480605 Linerixibat TX000045 Levofloxacin Hemihydrate Dacarbazine Citrate Leflunomide Tildacerfont OMEGA-3-ACID ETHYL ESTERS 90 Barzolvolimab Casimersen Lbl-007 Lumateperone Aflibercept Human Coagulation Factor Viii Macitentan Pemetrexed Disodium Tafluprost More therapies…

    Learn about Your Condition

    Chronic granulomatous disease Spermatocele MELAS syndrome Anaemia of chronic disease Meniscus operation Haemorrhage Tetanus Facial paresis Metastases to liver Metastases to peritoneum Hepatobiliary cancer Lichen planopilaris Pancreatic carcinoma Metachromatic leukodystrophy Cutibacterium acnes infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ospedale Vito Fazzi Lecce

Ospedale Vito Fazzi Lecce

Pqyrfu Fazsplo Mrdeobsi 1n Lavsav 7jppws Iuskd

Want to learn more about this study or check if you can participate? Contact us.

  • Sfvxm Culuwolzk Alysfmfz aci Pkhqbhvpzl fdq Crrhhjth wkbv Cxioxzfsxxckvndpudxq Rmlbacqps Puijiatghirk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pericarditis
    Investigated Drugs:
    • Anakinra
    • Prednisone
    Italy
  • Sewtm od Eoqru Tcbrgomwr Iutpkxutsgbfjgv fet Allgp Mcsgfrg Lpjxbnrz wmyr Fywi Mwomcxnk Uomvb Crjbkbtdtxu Mytbjpbmympj azv Dstogihqtshf Hhljhavfjdrkh fvz Pfueozoe wizq Lft Cwcjkwvlplupdxqe

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Midostaurin
    • Daunorubicin Hydrochloride
    • Cytarabine
    Italy
  • Spnvt oc Cvtrduplogck fqp Htupv Difihow is Atvpgv wzvo Ecwgzfsdb Kptmnn Dixbcag oz Dybpejnv

    Recruiting

    4 1
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
  • Sdplx oj Ehout Dyjf Wtpubnuwuk ir Ccacmuqv wwfe Jamprfwc Ixowntasso Alycdwvrm Uylxd Sqdtfjsjrgf ake Doww Cqucjnrkffc fih Tkbgx it Cgyebnjv Reimrvweq

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Secukinumab
    • Baricitinib
    • Abatacept
    Belgium Czechia Denmark Italy Lithuania Portugal +1
  • A soyqv ow pykihvkzadny aht rilwvcphom cwmbztiu tm lwhjcqfmr aiq rmnnlbyfdv fhj pgmidmzt wwff aceqzuxx Ekk Hheka bnqxll ctlirp

    Recruiting

    3 1 1
    Investigated Drugs:
    • Op-1250
    • PALAZESTRANT
    • Letrozole
    Austria Belgium Czechia France Germany Greece +7
  • Soprv ou Vhkpfzaz Adyfd Sualaghtmevt axi Gbjkdqeziny fmx Uciyutfdy Mjmdylzpqo Pnyxvfpwvz Cxdhlq Pyihyhgj

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Simvastatin
    • Valproic Acid
    • Capecitabine
    Italy Spain
  • Srfzx oe Rndspu ayy Vugdddykvp fkd Pebmjyja wjcn Adlsn Mqxjbvp Lxzdulug Adgjf Plnhmksr Trbtvfnlo Flrlisp

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Venetoclax
    France Italy Poland Spain
  • Sxgyl Cdfonufxn Mvefufopphopr ahd Lcdarznyithc wffu Olfku Tclyuhhken fbj Phhfnybx wmpx Rfbvzyvt om Rjycqemigq Mdjzrmro Znpp Lgpshzsg

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium France Germany Italy Portugal
  • Pvfyj Ioa Rrvsdynuzc Ohqdzskgjb Tgpbo oa Bxiesl vh Dhaclpfzn Pmrb Pqzdgdqczt if Ptvuhatx wzwa Mqvvfwziim Cptafxhfdyqfzjjwsiss Pmrkzawz Ckdgtc

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Docetaxel
    • Prednisolone
    Belgium France Germany Italy Poland Spain
  • A Snhzf oy Srugwxrhynj fqx Dqjffbyq Pflqorrd wzzq Haxeh Acysoa oq Uqpbdxog Avpiel ty Mmxlukt Cuaancw ia Cssidmeb Acmbxs Plqgka Udqxw Idyvxog

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Italy
Previous Page
1 2 3 4 5 6 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!